The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
about
Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferationLymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activityLymphangiogenesis and Inflammation-Looking for the "Missing Pieces" of the Puzzle.Defining stem and progenitor cells within adipose tissue.An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cellsThe new era of the lymphatic system: no longer secondary to the blood vascular systemRadiogenic lymphangiogenesis in the skinCCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion.Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo.Heterogeneity and plasticity of lymphatic endothelial cells.Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer.Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.Expression and clinical implication of cyclooxygenase-2 and e-cadherin in oral squamous cell carcinomas.Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining.A dual 5α-reductase inhibitor dutasteride caused reductions in vascular density and area in benign prostatic hyperplasia.Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance.Immunolocalization of lymphatic vessels in human fetal knee joint tissues.Solitary superficial microcystic lymphatic malformation (lymphangioma circumscriptum) of the gingiva.Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.Heterogeneity of tumor lymphangiogenesis: Progress and prospects
P2860
Q27315862-B8F48A9E-30F3-4DD9-A22A-5BE3C22A054FQ28584887-B4035F8A-25B8-4775-846F-2CB5B72C3E04Q33361133-8495A381-F3A4-4BCC-A4D5-8CD777A9C071Q33834898-83D0E097-B024-4481-AFC0-42479CF231ADQ33997193-2579E651-2882-4890-8123-21E7AB2940A9Q35852994-4214C738-CF3D-45BF-8CD6-C1590B2DC1DDQ35928217-B9E4D096-7082-4B49-B4AA-8206F6B09354Q36095617-6AC60B45-3F68-42D8-89F0-FCE906DEA917Q36319690-F6F67344-D374-4D5E-8E73-98FB7C49C913Q36612618-E599F161-A238-438E-9A73-E76962369BAAQ36838677-8588CF48-0779-4157-B74F-69918AACA731Q37343915-CF166D8F-3818-46E6-BF63-4357D36DB78DQ37758600-6DA5CF12-7F0F-4F64-A3D3-3C45D21F1575Q37947968-9FBAC253-0D62-4B7D-B32C-B7F77A52A711Q37968183-27E23909-C18E-4D33-94DC-C067AE10C18AQ38051085-DC0A4367-0718-41F7-8E45-B84DBEEFC056Q38984247-F4F8BF3F-29DD-4A6C-A833-C6A95811E1D7Q40686914-1EF33AAB-0BFD-4D9B-B7D1-AECC106A3A9DQ41316135-20A32682-3697-4EB1-9D8D-E0AE0397ACBEQ42103713-63741647-489A-4E37-BD81-64ECDD8D77F0Q42484870-D979AF08-DC8A-4607-B103-E1B51A896420Q43119911-0BEDCD00-43BF-4EA2-9FDA-62E43DFBFC2EQ52004942-0C175C4C-1426-42C8-A8B7-61B9A1B2FA35Q54794255-A4497D9D-499F-41EF-83D0-6529D53695D4Q58709934-063D9521-5B72-4BE7-9DBF-09D0649C91C8
P2860
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
@en
type
label
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
@en
prefLabel
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
@en
P2093
P2860
P1476
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
@en
P2093
David O Bates
Gerhard Christofori
Hellmut G Augustin
Maxine S Emmett
Stefanie Koidl
Sven Christian
Ulrike Fiedler
P2860
P304
P356
10.2353/AJPATH.2006.050554
P407
P577
2006-03-01T00:00:00Z